miRNA is a set of small, non-coding RNA molecules that regulate gene expression post transcription. These molecules have an impact on a wide range of biological functions such as cell cycle control, stem cell differentiation, immune modulation, viral replication, and metabolic control. As the aforementioned processes are involved in the pathology of various diseases, tests performed on miRNAs help in disease treatment. Moreover, miRNAs can be easily manipulated than proteins, thus making them more useful for clinical diagnostics and therapeutics applications.

The global miRNA tools and services market was valued at $146 million in 2015 and is expected to reach $620 million by 2022, growing at a CAGR of 23.4% during the forecast period. It is expected to witness significant growth owing to the rise in incidence of cancer, auto-immune, and cardiovascular diseases. In addition, miRNA molecules possess specific properties, such as higher tissue and organ specificity; and ability to cross the blood-brain barrier easily, that make them a favorable option to be used as biomarkers for a variety of neurological diseases, thereby driving the market growth. However, quantification challenges and development of in-use techniques, such as microarray, hamper the market growth.

The global miRNA tools and services market is segmented on the basis of product, technique, end user, and geography. The miRNA tools and services market is bifurcated into research tools and services. Research tools market is further divided into reagents, kits, and consumables. On the other hand, the services market is classified into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. Based on techniques, the market is segmented into extraction tools, qRT-PCR, NGS, microarray, functional analysis tools (such as miRNA mimetics, inhibitors, and target site blockers), and others (such as labeling, ISH, and northern blotting tools). The end-user market is divided into research & academic institutes; IVD, pharma, and biotech companies; and CROs. The market is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

Prominent players have adopted product development (including product launches and approvals) as their key developmental strategy to expand their product portfolio. For instance, in April 2010, NanoString Technologies, Inc. launched a new assay kit for miRNA analysis, which includes the multiplexed assay for profiling the human miRNA transcriptome in a single tube. This assay kit facilitates in direct digital detection and counting of miRNAs without the use of PCR amplification.

Key Benefits

This report provides an extensive analysis of the current trends, emerging estimations, and dynamics in the global miRNA tools and services market from 2014 to 2022.
Comprehensive analysis of all regions is provided to determine the prevailing market opportunities.
It presents a detailed quantitative analysis and estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- and country-wise market conditions are comprehensively analyzed.

miRNA Tools and Services Market Key Segments

By Product

Research Tools
Kits
Reagents
Other Consumables
Services
miRNA Extraction Services
Quantification Services
Microarray Services
Sequencing Services
Functional Studies Services
Others

By Technology

Extraction Tools
qRT-PCR
NGS
Microarray
Functional Analysis Tools
Others

By End User

Research & Academic Institutes
IVD, Pharma, and Biotech Companies
CROs

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Indonesia
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Colombia
Argentina
Rest of LAMEA

The key players profiled in this report are as follows:

QIAGEN (Exiqon)
Thermo Fisher Scientific Inc.
Illumina, Inc.
Agilent Technologies
GE Healthcare Dharmacon Inc.
GeneCopoeia, Inc.
Promega Corporation
Bio-Rad Laboratories, Inc.
Merck & Co., Inc.
New England Biolabs

Other players operating in the miRNA tools and services market include:

WaferGen Biosystems
NanoString Technologies, Inc.
HTG Molecular Diagnostics, Inc.
OriGene Technologies, Inc.
Quantabio
Miltenyi Biotec
Norgen Biotek Corp.